Baidu
map

卫健委:中国免疫规划疫苗接种率持续保持在90%以上

2019-02-25 佚名 中国新闻网

全国政协委员、中国疾控中心主任高福25日表示,大家不要对疫苗可防控疾病的疫苗免疫、疫苗接种失去信心,更不要对中国的疫苗失去信心,中国免疫规划疫苗的接种率持续保持在90%以上,有这样的覆盖率,传染病可以得到很好的防控。


全国政协委员、中国疾控中心主任高福25日表示,大家不要对疫苗可防控疾病的疫苗免疫、疫苗接种失去信心,更不要对中国的疫苗失去信心,中国免疫规划疫苗的接种率持续保持在90%以上,有这样的覆盖率,传染病可以得到很好的防控。

25日,卫健委就全国“两会”代表委员谈健康举行例行发布会。会上中国疾控中心主任高福介绍过去一年来我国在疾病预防控制和公共卫生方面所做的工作。

高福介绍,过去一年里,疾病预防控制主要工作之一,就是不断地在完善在疾病预防控制方面的法律法规、政策体系。目前在疾控工作直接相关的法律现在有八部,行政法规有十部,部门规章有十七部,工作规划或者行动计划有十八个,可以看到在这个疾病预防控制方面已经形成了比较好的完善的法律法规政策体系,这是国家法治的一个典型代表。去年一年在卫生健康委党组的领导下,疾病预防控制公共卫生战线的同志们在这方面做了大量的工作,现在已经初步建立了疾控机构医院、基层医疗卫生机构分工协作、上下联动、优势互补的重大疾病的防、治、管这样的服务网络。实现了对39种法定传染病病例、个案信息和突发公共卫生事件的实时在线监测、实名登记、慢病防控等一系列体系的建设。

高福继续补充了中国在疾病预防控制和公共卫生方面所做的其它几个方面工作:

在传染病、地方病和职业病防控上取得了很大的成效。中国有疫苗可防控疾病,尽管去年以来有这个事件、那个事件可能跟疫苗有关系,但是大家不要对疫苗可防控疾病的疫苗免疫、疫苗接种失去信心,更不要对中国的疫苗失去信心,我国免疫规划疫苗的接种率持续保持在90%以上,有这样的覆盖率,传染病可以得到很好的防控。在艾滋病、结核病、血吸虫病这一系列的重点疾病方面去年一年以来取得了比较好的成就。地方病,碘缺乏症,已经有全国94.2%的县保持消除碘缺乏症,也对一些重点职业病、信息化建设去年开通了好多网络建设。

慢性病防治和精神卫生工作稳步推进。全国建成365个国家级慢性病综合防控示范区,在这方面确实发挥了以点代面,推动整体,带动全国,这是通过示范区发挥示范作用,通过这样的示范最后在全国进行推广。在癌症的早诊早治、血管疾病的高危筛查干预、口腔疾病的综合干预等等都做了大量的工作,这些工作是最容易让老百姓(57.640, 3.22, 5.92%)有获得感,有了获得感就会有幸福感。同时,贯彻落实精神卫生法,会同22个部门印发了《关于加强心理健康服务的指导意见》,在精神卫生方面做了大量的工作。

环境健康和学校卫生工作的加强。全国环境健康卫生的监测网络,中国的覆盖面逐年在加强,现在覆盖率是所有县区县内和90%以上的乡镇有关饮用水,人类整个寿命的延长,其实最重要的一个问题解决了饮用水,饮用水是很关键的,然后才解决了传染病。有关环境健康方面做了大量工作。学校卫生工作,尤其是在解决“小眼镜”也就是近视,小胖墩也就是肥胖这方面做了大量的工作,2018年8个部门联合印发了《综合防控儿童青少年近视实施方案》,联合教育部、财政部开展儿童青少年近视的调查工作,加强专业指导和健康宣传。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2080435, encodeId=d3042080435bf, content=<a href='/topic/show?id=3faa2916ed1' target=_blank style='color:#2F92EE;'>#免疫规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29167, encryptionId=3faa2916ed1, topicName=免疫规划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Sat Mar 16 13:24:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078659, encodeId=504e20e865995, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Dec 21 13:24:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672515, encodeId=6eed16e2515de, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Fri May 10 08:24:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257866, encodeId=b690125e866f2, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Feb 27 13:24:00 CST 2019, time=2019-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258564, encodeId=3c0312585641d, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Feb 27 13:24:00 CST 2019, time=2019-02-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2080435, encodeId=d3042080435bf, content=<a href='/topic/show?id=3faa2916ed1' target=_blank style='color:#2F92EE;'>#免疫规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29167, encryptionId=3faa2916ed1, topicName=免疫规划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Sat Mar 16 13:24:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078659, encodeId=504e20e865995, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Dec 21 13:24:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672515, encodeId=6eed16e2515de, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Fri May 10 08:24:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257866, encodeId=b690125e866f2, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Feb 27 13:24:00 CST 2019, time=2019-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258564, encodeId=3c0312585641d, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Feb 27 13:24:00 CST 2019, time=2019-02-27, status=1, ipAttribution=)]
    2019-12-21 gous
  3. [GetPortalCommentsPageByObjectIdResponse(id=2080435, encodeId=d3042080435bf, content=<a href='/topic/show?id=3faa2916ed1' target=_blank style='color:#2F92EE;'>#免疫规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29167, encryptionId=3faa2916ed1, topicName=免疫规划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Sat Mar 16 13:24:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078659, encodeId=504e20e865995, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Dec 21 13:24:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672515, encodeId=6eed16e2515de, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Fri May 10 08:24:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257866, encodeId=b690125e866f2, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Feb 27 13:24:00 CST 2019, time=2019-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258564, encodeId=3c0312585641d, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Feb 27 13:24:00 CST 2019, time=2019-02-27, status=1, ipAttribution=)]
    2019-05-10 respect
  4. [GetPortalCommentsPageByObjectIdResponse(id=2080435, encodeId=d3042080435bf, content=<a href='/topic/show?id=3faa2916ed1' target=_blank style='color:#2F92EE;'>#免疫规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29167, encryptionId=3faa2916ed1, topicName=免疫规划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Sat Mar 16 13:24:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078659, encodeId=504e20e865995, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Dec 21 13:24:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672515, encodeId=6eed16e2515de, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Fri May 10 08:24:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257866, encodeId=b690125e866f2, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Feb 27 13:24:00 CST 2019, time=2019-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258564, encodeId=3c0312585641d, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Feb 27 13:24:00 CST 2019, time=2019-02-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2080435, encodeId=d3042080435bf, content=<a href='/topic/show?id=3faa2916ed1' target=_blank style='color:#2F92EE;'>#免疫规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29167, encryptionId=3faa2916ed1, topicName=免疫规划)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5462342, createdName=sunmin0219, createdTime=Sat Mar 16 13:24:00 CST 2019, time=2019-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078659, encodeId=504e20e865995, content=<a href='/topic/show?id=a34956696a7' target=_blank style='color:#2F92EE;'>#接种率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56696, encryptionId=a34956696a7, topicName=接种率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a9987, createdName=gous, createdTime=Sat Dec 21 13:24:00 CST 2019, time=2019-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672515, encodeId=6eed16e2515de, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Fri May 10 08:24:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1257866, encodeId=b690125e866f2, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Feb 27 13:24:00 CST 2019, time=2019-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258564, encodeId=3c0312585641d, content=<a href='/topic/show?id=b0ae365e02f' target=_blank style='color:#2F92EE;'>#卫健委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36570, encryptionId=b0ae365e02f, topicName=卫健委)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Wed Feb 27 13:24:00 CST 2019, time=2019-02-27, status=1, ipAttribution=)]

相关资讯

国家卫健委:12种抗癌新药纳入新版基本药物目录

今天国务院新闻办召开国务院政策例行吹风会,国家卫生健康委相关负责人介绍,我国进一步加大癌症防治用药保障力度,将临床急需的12种抗肿瘤新药纳入2018年版国家基本药物目录,使抗肿瘤药物的种类达到38种,其中不乏小分子靶向药等创新药物。针对抗癌药进医院最后一公里的问题,明确谈判药品费用不纳入总额控制范围,要求医疗机构不得以费用总控、“药占比”和医疗机构基本用药目录等为由影响谈判药品的供应和合理用药需求

国家卫健委全新领导分工

国家卫健委最新领导分工

国家卫健委:京沪等6省市今年将试点“互联网+护理服务”

国家卫生健康委网站2月12日消息,国家卫健委办公厅近日印发开展“互联网+护理服务”试点工作通知。通知称,为贯彻《国务院办公厅关于促进“互联网+医疗健康”发展的意见》(国办发〔2018〕26号),落实我委等11部门《关于促进护理服务业改革与发展的指导意见》,规范“互联网+护理服务”,保障医疗质量和安全,助力实施健康中国战略,经研究,我委确定北京市、天津市、上海市、江苏省、浙江省、广东省作为“互联

国家卫健委掌舵,未来口腔市场的三大趋势!

2019年2月15日,国家卫健委办公厅发布了《关于印发健康口腔行动方案(2019—2025年)的通知》,结合当前中国居民口腔健康状况和口腔卫生工作现况对未来7年作出了规划和要求。

刚刚!国家卫健委发布乡村医生证再注册通知

刚刚,国家卫生健康委发布《关于做好乡村医生执业证书有效期满再注册工作的通知》,村医必看!刚刚,国家卫生健康委办公厅发布了《关于做好乡村医生执业证书有效期满再注册工作的通知》(下文简称《通知》),要求地方各级卫生健康行政部门对获得乡村医生执业证书满5年的村医进行执业再注册工作。5年一换证,乡村医生进入新一轮换证期2004年1月1日起《乡村医生从业管理条例》(以下简称《条例》)正式实施。《条例》明

国家卫健委:全国**贫困县县医院实现远程医疗全覆盖

2月13日,记者从国家卫健委召开的卫生健康对口支援工作进展有关情况发布会上获悉,通过聚焦健康扶贫,我国实现了所有国家级贫困县县医院远程医疗全覆盖,1180家县级医院获得了三级医院的对口帮扶。国家卫生健康委医政医管局副局长焦雅辉介绍,对口支援工作开展以来,工作力度不断加大,各项举措不断深化,已实现所有国家级贫困县县医院远程医疗全覆盖。截至2018年底,三级医院已派出超过6万人次医务人员参与贫困县县级

Baidu
map
Baidu
map
Baidu
map